Literature DB >> 33553692

Ligand-competent fractalkine receptor is expressed on exosomes.

Eun Jeong Park1, Phyoe Kyawe Myint1, Michael G Appiah1, Patsorn Worawattananutai1, Janjira Inprasit1, Onmanee Prajuabjinda1, Zay Yar Soe1, Arong Gaowa1, Eiji Kawamoto1,2, Motomu Shimaoka1.   

Abstract

Expression of chemokine receptor CX3CR1 is reportedly restricted to several cell types including natural killer cells, cytotoxic T cells, monocytes, and macrophages. However, its expression and function on exosomes, which are nanosized extracellular vesicles known to act as mediators of intercellular communications, remain unclear. Here, we investigated CX3CR1 expression on exosomes isolated from various cell types. Although we found that all the exosomes tested in our study highly expressed CX3CR1, this chemokine receptor was expressed only inside, but barely on, their source cells. Moreover, exosomal CX3CR1 was capable of binding soluble CX3CL1. Therefore, our study suggests that CX3CR1 is a novel and ligand-competent exosome receptor.
© 2021 The Author(s).

Entities:  

Keywords:  CX3CR1; Chemokine; Chemokine receptor; Exosome; Fractalkine

Year:  2021        PMID: 33553692      PMCID: PMC7859287          DOI: 10.1016/j.bbrep.2021.100932

Source DB:  PubMed          Journal:  Biochem Biophys Rep        ISSN: 2405-5808


  36 in total

1.  Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting.

Authors:  F Reggiori; H R Pelham
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

Review 2.  Intestinal macrophages - specialised adaptation to a unique environment.

Authors:  Calum C Bain; Allan McI Mowat
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

3.  Exosomal regulation of lymphocyte homing to the gut.

Authors:  Eun Jeong Park; Onmanee Prajuabjinda; Zay Yar Soe; Samuel Darkwah; Michael G Appiah; Eiji Kawamoto; Fumiyasu Momose; Hiroshi Shiku; Motomu Shimaoka
Journal:  Blood Adv       Date:  2019-01-08

4.  RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis.

Authors:  Duncan I Mackie; Natalie R Nielsen; Matthew Harris; Smriti Singh; Reema B Davis; Danica Dy; Graham Ladds; Kathleen M Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

5.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  A clonogenic bone marrow progenitor specific for macrophages and dendritic cells.

Authors:  Darin K Fogg; Claire Sibon; Chaouki Miled; Steffen Jung; Pierre Aucouturier; Dan R Littman; Ana Cumano; Frederic Geissmann
Journal:  Science       Date:  2005-12-01       Impact factor: 47.728

7.  Ubiquitination of CXCR7 controls receptor trafficking.

Authors:  Meritxell Canals; Danny J Scholten; Sabrina de Munnik; Mitchell K L Han; Martine J Smit; Rob Leurs
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

8.  The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.

Authors:  Louise A Johnson; David G Jackson
Journal:  J Cell Sci       Date:  2013-09-04       Impact factor: 5.285

9.  Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8+ T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients.

Authors:  Melissa J Conroy; Stephen G Maher; Ashanty M Melo; Suzanne L Doyle; Emma Foley; John V Reynolds; Aideen Long; Joanne Lysaght
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

10.  Fetal Bovine Serum RNA Interferes with the Cell Culture derived Extracellular RNA.

Authors:  Zhiyun Wei; Arsen O Batagov; David R F Carter; Anna M Krichevsky
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

View more
  1 in total

Review 1.  Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy.

Authors:  Hamzeh Sarvnaz; Maedeh Arabpour; Samira Molaei Ramshe; Reza Hosseini; Leila Asef-Kabiri; Hassan Yousefi; Mohammad Esmaeil Akbari; Nahid Eskandari
Journal:  Mol Cancer       Date:  2022-01-14       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.